Search Results

You are looking at 91 - 100 of 714 items for :

  • All content x
Clear All
Open access

Taísa A R Vicente, Ívina E S Rocha, Roberto Salvatori, Carla R P Oliveira, Rossana M C Pereira, Anita H O Souza, Viviane C Campos, Elenilde G Santos, Rachel D C Araújo Diniz, Eugênia H O Valença, Carlos C Epitácio-Pereira, Mario C P Oliveira, Andrea Mari, and Manuel H Aguiar-Oliveira

effect is likely to be completely absent). It is conceivable that the lack of a GHRH effect per se may have additional consequences on glucose metabolism independent of GHD. It is also possible that the self-reporting approach may have underestimated

Open access

M Ahmid, C G Perry, S F Ahmed, and M G Shaikh

, although the evidence base underlying this recommendation is limited ( 8 ). Figure 1 GH–IGF1 axis and actions in bone, muscle and body metabolism. GH secretion is regulated by three peptides: GH-releasing hormone (GHRH), ghrelin-stimulating GH

Open access

Esben Thyssen Vestergaard, Morten B Krag, Morten M Poulsen, Steen B Pedersen, Niels Moller, Jens Otto Lunde Jorgensen, and Niels Jessen

the period from t =120 to t =300 min as the clamp period. Serum RBP4 levels were measured twice each study day: at baseline ( t =−60 min) and during the clamp at t =300 min. Data on glucose metabolism, insulin sensitivity, and energy expenditure

Open access

Adriano N Cury, Verônica T Meira, Osmar Monte, Marília Marone, Nilza M Scalissi, Cristiane Kochi, Luís E P Calliari, and Carlos A Longui

Pediatric Endocrinology and Metabolism 2001 14 229 – 243 . ( doi:10.1515/JPEM.2001.14.3.229 ). 2 Kaguelidou F Carel JC Leger J . Graves' disease in childhood: advances in management with antithyroid drug therapy

Open access

E Vignali, F Cetani, S Chiavistelli, A Meola, F Saponaro, R Centoni, L Cianferotti, and C Marcocci

levels (e.g. Paget's disease) should be excluded. Finally, the use of medications which might affect PTH levels or calcium metabolism (estrogens, thiazide diuretics, lithium, bisphosphonates, denosumab and anticonvulsants) should also be ruled out (4

Open access

David P Sonne, Asger Lund, Jens Faber, Jens J Holst, Tina Vilsbøll, and Filip K Knop

labelled as detergents necessary for lipid digestion and absorption, but are increasingly recognised as metabolic integrators, capable of regulating glucose homeostasis, lipid metabolism and energy expenditure through nuclear receptors and the G protein

Open access

Meena Asmar, Ali Asmar, Lene Simonsen, Flemming Dela, Jens Juul Holst, and Jens Bülow

Introduction The regulation of subcutaneous adipose tissue blood flow (ATBF) is crucial in lipid homeostasis ( 1 , 2 ). It has long been recognized that the ATBF is tightly coupled to adipose tissue metabolism ( 3 , 4 , 5 , 6 ). In

Open access

Carla Scaroni, Nora M Albiger, Serena Palmieri, Davide Iacuaniello, Chiara Graziadio, Luca Damiani, Marialuisa Zilio, Antonio Stigliano, Annamaria Colao, Rosario Pivonello, and the Altogether to Beat Cushing’s Syndrome (ABC) study group

assessing cortisol and cortisone levels ( 9 ). The concomitant use of commonly prescribed therapies may alter dexamethasone metabolism, interfering with its use in a suppression test. Some types of medication can interfere with the CYP3A4 enzyme system

Open access

Ursula M M Costa, Carla R P Oliveira, Roberto Salvatori, José A S Barreto-Filho, Viviane C Campos, Francielle T Oliveira, Ivina E S Rocha, Joselina L M Oliveira, Wersley A Silva, and Manuel H Aguiar-Oliveira

. References 1 Aguiar-Oliveira MH & Salvatori R. Lifetime growth hormone (GH) deficiency: impact on growth, metabolism, body composition, and survival capacity Chapter ID 160. In Handbook of Growth and Growth Monitoring in Health and Disease . Ed VR Preedy

Open access

J Chycki, A Zajac, M Michalczyk, A Maszczyk, and J Langfort

metabolism, the white adipose tissue (WAT) also referred to as subcutaneous or visceral fat (intraabdominal: mesenteric, perirenal and epididymal depots) serves as a primary energy store, and lipolysis in WAT is a crucial process for whole-body energy